Inventor · disambiguated record
Dror Harats
Also filed as: HARATS DROR
31 granted patents·19 pending applications·550 citations·filing 1995–2024
98Inventor score
Files withVASCULAR BIOGENICS LTD21HARATS DROR10MEMORIAL SLOAN KETTERING CANCER CENTER3NIKKEN SOHONSHA CORP3TEL HASHOMER MEDICAL RES INFRASTRUCTURE & SERVICES LTD2
Top patents by PatentIndex Score
50 records- 0196US7973023B2Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disordersVASCULAR BIOGENICS LTD·Filed 2009·Granted Jul 5, 2011·31 cites·51 claims
- 0296US7504388B2Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosisVASCULAR BIOGENICS LTD·Filed 2005·Granted Mar 17, 2009·31 cites·7 claims
- 0396US6838452B2Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosisVASCULAR BIOGENICS LTD·Filed 2003·Granted Jan 4, 2005·62 cites·11 claims
- 0495US8158611B2Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosisHARATS DROR·Filed 2011·Granted Apr 17, 2012·18 cites·13 claims
- 0595US7893291B2Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosisVASCULAR BIOGENICS LTD·Filed 2009·Granted Feb 22, 2011·24 cites·3 claims
- 0695US7625882B2Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disordersVASCULAR BIOGENICS LTD·Filed 2006·Granted Dec 1, 2009·31 cites·56 claims
- 0793US7989427B2Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapyVASCULAR BIOGENICS LTD·Filed 2008·Granted Aug 2, 2011·21 cites·6 claims
- 0893US7186704B2Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosisVASCULAR BIOGENICS LTD·Filed 2003·Granted Mar 6, 2007·31 cites·16 claims
- 0992US8039261B2Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesisVASCULAR BIOGENICS LTD·Filed 2006·Granted Oct 18, 2011·27 cites·39 claims
- 1092US7902176B2Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disordersVASCULAR BIOGENICS LTD·Filed 2004·Granted Mar 8, 2011·31 cites·107 claims
- 1191US8415318B2Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapyHARATS DROR·Filed 2011·Granted Apr 9, 2013·14 cites·26 claims
- 1291US8206743B2Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesisHARATS DROR·Filed 2011·Granted Jun 26, 2012·14 cites·26 claims
- 1391US7067649B2Promoters exhibiting endothelial cell specificity and methods of using sameVASCULAR BIOGENICS LTD·Filed 2002·Granted Jun 27, 2006·40 cites·19 claims
- 1490US8563534B2Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosisHARATS DROR·Filed 2012·Granted Oct 22, 2013·8 cites·21 claims
- 1590US7585666B2Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapyVASCULAR BIOGENICS LTD·Filed 2002·Granted Sep 8, 2009·29 cites·5 claims
- 1689US8501715B2Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disordersHARATS DROR·Filed 2011·Granted Aug 6, 2013·8 cites·26 claims
- 1788US7579327B2Promoters exhibiting endothelial cell specificity and methods of using sameVASCULAR BIOGENICS LTD·Filed 2004·Granted Aug 25, 2009·23 cites·10 claims
- 1887US8071740B2Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesisHARATS DROR·Filed 2004·Granted Dec 6, 2011·19 cites·21 claims
- 1985US8835398B2Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesisHARATS DROR·Filed 2012·Granted Sep 16, 2014·6 cites·35 claims
- 2085US5747340ATargeted gene expression using preproendothelin-1 promotersSYNTEX INC·Filed 1995·Granted May 5, 1998·53 cites·15 claims
- 2184US8859745B2Promoters exhibiting endothelial cell specificity and methods of using sameHARATS DROR·Filed 2009·Granted Oct 14, 2014·5 cites·32 claims
- 2284US8859747B2Promoters exhibiting endothelial cell specificity and methods of using sameVASCULAR BIOGENICS LTD·Filed 2013·Granted Oct 14, 2014·5 cites·31 claims
- 2384US8846401B2Promoters exhibiting endothelial cell specificity and methods of using sameHARATS DROR·Filed 2012·Granted Sep 30, 2014·5 cites·34 claims
- 2483US8916378B2Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulations of angiogenesis and anticancer therapyVASCULAR BIOGENICS LTD·Filed 2013·Granted Dec 23, 2014·4 cites·20 claims
- 2577US8529907B2Methods of treating ophthalmic disordersBELKIN MICHAEL·Filed 2009·Granted Sep 10, 2013·3 cites·11 claims
- 2673US7264813B2Therapeutic uses of Dunaliella powderTEL HASHOMER MEDICAL RES INFRASTRUCTURE & SERVICES LTD·Filed 2003·Granted Sep 4, 2007·5 cites·12 claims
- 2772US7279459B2Methods employing and compositions containing plaque associated molecules for prevention and treatment of atherosclerosisVASCULAR BIOGENICS LTD·Filed 2002·Granted Oct 9, 2007·2 cites·8 claims
- 2870US2021069330A1Methods and compositions for tumor radiosensitizationMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Application pending·0 cites
- 2968US2010081193A1Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesisVASCULAR BIOGENICS LTD·Filed 2009·Application pending·0 cites
- 3065US2018015183A1Method and composition to increase radiation-induced tumor therapeutic effectsMEMORIAL SLOANE-KETTERING CANCER CENTER·Filed 2017·Application pending·0 cites
- 3159US7763255B2Therapeutic uses of Dunaliella powderNIKKEN SOHONSHA CORP·Filed 2007·Granted Jul 27, 2010·0 cites·8 claims
- 3259US2024271135A1Composition comprising an rna therapeutic targeting fat10 and uses of same for treating disorders characterized by abnormal lipid accumulationSHEBA IMPACT LTD·Filed 2024·Application pending·0 cites
- 3359US2017007718A1Method and composition to increase radiation-induced tumor therapeutic effectsMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2015·Application pending·0 cites
- 3455US2012252883A1Method and Composition to Increase Radiation-Induced Tumor Therapeutic EffectsKOLESNICK RICHARD N·Filed 2010·Application pending·0 cites
- 3555US2005148499A1Compositions containing beta 2-glycoprotein I for the prevention and/or treatment of atherosclerosisFiled 2004·Application pending·0 cites
- 3655US2011201677A1Promoters exhibiting endothelial cell specificity and methods of using sameVASCULAR BIOGENICS LTD·Filed 2011·Application pending·0 cites
- 3755US2011207985A1Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesisVASCULAR BIOGENICS LTD·Filed 2011·Application pending·0 cites
- 3854US2007286845A1Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesisVASCULAR BIOGENICS LTD·Filed 2007·Application pending·0 cites
- 3953US8961993B2Method of treating retinitis pigmentosaNIKKEN SOHONSHA CORP·Filed 2013·Granted Feb 24, 2015·0 cites·11 claims
- 4051US8343549B2Therapeutic uses of Dunaliella powderNIKKEN SOHONSHA CORP·Filed 2010·Granted Jan 1, 2013·0 cites·15 claims
- 4151US2014155467A1Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesisVASCULAR BIOGENICS LTD·Filed 2013·Application pending·0 cites
- 4250US2005197283A1Compositions containing beta 2-glycoprotein I for the prevention and/or treatment of vascular diseaseVASCULAR BIOGENICS LTD·Filed 2005·Application pending·0 cites
- 4350US2022175860A1Dunaliella alga preparation for prevention and/or treatment of a neurodegenerative disease, a disorder associated with protein misfolding and cognitive declineTEL HASHOMER MEDICAL RES INFRASTRUCTURE & SERVICES LTD·Filed 2020·Application pending·0 cites
- 4448US2016279202A1Interleukin-1 (il-1) inhibitors for treating fertility disordersRAMOT AT TEL-AVIV UNIV LTD·Filed 2014·Application pending·0 cites
- 4548US2010282634A1Promoters Exhibiting Endothelial Cell Specificity and Methods of Using Same for Regulation of AngiogenesisHARATS DROR·Filed 2007·Application pending·0 cites
- 4647US9180152B2Method for treating psoriasisSHAISH AVIV·Filed 2010·Granted Nov 10, 2015·0 cites·3 claims
- 4746US2002025321A1Composition for the prevention and/or treatment of atherosclerosisFiled 2001·Application pending·0 cites
- 4843US2018015184A1Method and composition to increase radiation-induced tumor therapeutic effectsMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2016·Application pending·0 cites
- 4941US2004048280A1Promoters exhibiting endothelial cell specificity and methods of using sameFiled 2001·Application pending·0 cites
- 5031US2003114367A1Composition for the prevention and/or treatment of artherosclerosisFiled 1999·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dror Harats files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →